Table:
| Name | Grant Date | Number of Securities Underlying Restricted Stock Awards and Restricted Stock Units (#) | Number of Securities Underlying Options (#) | Exercise or Base Price of Option Awards ($/Sh) | Grant Date Fair Value of Stock and Option Awards ($) (1) |
| --- | --- | --- | --- | --- | --- |
| Mr. Dorsey | — | — | — | — | — |
| Ms. Friar | 4/25/2018 | 38,159 | 109,026 | 44.75 | 3,479,299 |
| Ms.Henry | 4/25/2018 | 38,159 | 109,026 | 44.75 | 3,479,299 |
| Ms. Reses | 4/25/2018 | 38,159 | 109,026 | 44.75 | 3,479,299 |
| Ms. Whiteley | 4/25/2018 | 16,695 | 47,699 | 44.75 | 1,522,215 |
| Mr. Daswani | 4/25/2018 | 4,198 | — | — | 187,861 |
| Mr. Murphy | 4/25/2018 | 4,962 | — | — | 222,050 |
Paragraphs:
Grants of Plan-Based Awards in 2018
The following table sets forth information regarding grants of awards made to our named executive officers during 2018. We did not grant any plan-based cash awards during 2018.
(1) The amounts included in this column represent the aggregate grant date fair value of RSUs, RSAs and option awards calculated in accordance with ASC 718. The valuation assumptions used in determining the grant date fair value of the RSUs, RSAs and options reported in this column are described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
Question:
What is the ratio of Ms. Henry’s to Ms. Whiteley’s Number of Securities Underlying Options?
Answer: 109026 / 47699  = 2.29